Mizuho analyst, Irina Koffler, thinks Allergan (NYSE: AGN) is fully priced as a standalone entity but the stock can ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE